Need for revision of diagnostic limits for medullary thyroid carcinoma with a new immunochemiluminometric calcitonin assay

Clinical Chemistry

Volumn 55, Issue 12, 2009, Pages 2225-2226

  Ramachandran, Radha ^a,b   Benfield, Patricia ^a   Dhillo, Waljit S ^b   White, Sara ^a   Chapman, Richard ^a,b   Meeran, Karim ^b   Donaldson, Mandy ^a   Martin, Niamh M ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; MONOCLONAL ANTIBODY; PENTAGASTRIN;

BLOOD SAMPLING; CALCITONIN BLOOD LEVEL; CHEMOLUMINESCENCE; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HORMONAL REGULATION; HUMAN; IMMUNOCHEMILUMINESCENT ASSAY; IMMUNOCHEMISTRY; IMMUNORADIOMETRIC ASSAY; LETTER; SENSITIVITY AND SPECIFICITY; SERUM; THYROID FUNCTION TEST; THYROID MEDULLARY CARCINOMA; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; CALCITONIN; CARCINOMA, MEDULLARY; CHEMILUMINESCENT MEASUREMENTS; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SEX FACTORS; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 71749116483     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.129361     Document Type: Letter

References (5)

1. Barbot N, Calmettes C, Schuffenecker I, Saint- Andre JP, Franc B, Rohmer V, et al. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab 1994;78:114-120 (Pubitemid 24026758)
2. Scheuba C, Kaserer K, Moritz A, Drosten R, Vierhapper H, Bieglmayer C, et al. Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer 2009;16:243-253
3. Bieglmayer C, Vierhapper H, Dudczak R, Niederle B. Measurement of calcitonin by immunoassay analyzers. Clin Chem Lab Med 2007;45:662-666
4. Cavalier E, Carlisi A, Chapelle J, Delanaye P. Analytical quality of calcitonin determination and its effect on the adequacy of screening for medullary carcinoma of the thyroid. Clin Chem 2008;54:929-930 (Pubitemid 351671615)
5. d'Herbomez M, Caron P, Bauters C, Cao CD, Schlienger J, Sapin R, et al., and the French Group GTE (Groupe des Tumeurs Endocrines). Reference range of serum calcitonin levels in humans: Influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 2007;157:749-755